{"id":851,"date":"2026-05-25T03:49:50","date_gmt":"2026-05-25T03:49:50","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=851"},"modified":"2026-08-19T02:24:07","modified_gmt":"2026-08-19T02:24:07","slug":"bpc-157-5mg-10mg","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/bpc-157-5mg-10mg\/","title":{"rendered":"BPC-157 (5mg \/ 10mg)"},"content":{"rendered":"

BPC-157 (5mg \/ 10mg) Research Peptide: A Stable Pentadecapeptide for Angiogenesis, GI & Musculoskeletal Studies<\/span><\/h1>\n

If your research investigates tissue repair, angiogenesis, or the molecular mechanisms of gastrointestinal protection and musculoskeletal healing,\u00a0<\/span>BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>\u00a0\u2014 also known as Body Protection Compound-157 \u2014 offers a precisely defined synthetic tool. This stable gastric pentadecapeptide was first described in 1993 in the\u00a0<\/span>Journal of Physiology, Paris<\/span><\/em>\u00a0as a naturally occurring peptide in gastric juice with cytoprotective properties<\/span>. BPC-157 has since been the subject of hundreds of preclinical studies exploring its ability to promote healing across multiple tissue types. <\/span><\/p>\n

What distinguishes BPC-157 is its remarkable stability and pleiotropic activity: it is native and stable in human gastric juice for more than 24 hours<\/span>, enhances growth hormone receptor expression<\/span>, and modulates several pathways involved in cell growth and angiogenesis while reducing inflammatory cytokines<\/span>. This makes\u00a0<\/span>BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>\u00a0a valuable tool for laboratories investigating wound healing, gastrointestinal protection, musculoskeletal repair, and angiogenesis.<\/span><\/p>\n

At\u00a0<\/span>Wuhan Top Miracle Peptides<\/span><\/strong>, we supply high\u2011purity\u00a0<\/span>BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>\u00a0to research institutions and wholesale buyers across the\u00a0<\/span>United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA<\/span><\/strong>. Every batch is lyophilised, HPLC\u2011verified to \u226598% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into tissue repair, angiogenesis, and cytoprotection begin with uncompromising quality.<\/span><\/p>\n

What Is BPC-157 and How Does It Work?<\/span><\/h2>\n

To fully appreciate the research potential of\u00a0<\/span>BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>, it is essential to understand its biochemical identity, its role as a stable gastric pentadecapeptide, and the mechanisms by which it exerts its pleiotropic effects.<\/span><\/p>\n

The Stable Gastric Pentadecapeptide<\/span><\/h3>\n

BPC-157 is a synthetic peptide consisting of 15 amino acids, derived from a naturally occurring peptide found in human gastric juice<\/span>. Its sequence is\u00a0<\/span>Gly\u2011Glu\u2011Pro\u2011Pro\u2011Pro\u2011Gly\u2011Lys\u2011Pro\u2011Ala\u2011Asp\u2011Asp\u2011Ala\u2011Gly\u2011Leu\u2011Val<\/span><\/strong>, with a molecular weight of approximately\u00a0<\/span>1499.7 g\/mol<\/span><\/strong>. It has a CAS number of\u00a0<\/span>137525-51-0<\/span><\/strong>. The peptide is notable for its stability in gastric juice, where it remains intact for more than 24 hours<\/span>. This stability is a key feature that distinguishes it from many other research peptides and contributes to its pleiotropic activity.<\/span><\/p>\n

Mechanism of Action: Cytoprotection, Angiogenesis and Organoprotection<\/span><\/h3>\n

The biological activity of\u00a0<\/span>BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>\u00a0is mediated through several intersecting mechanisms, rooted in the concept of cytoprotection \u2014 the innate ability of cells to protect themselves against injury:<\/span><\/p>\n

Cytoprotection and Gastrointestinal Protection<\/span><\/strong><\/p>\n

BPC-157 was first described as a cytoprotective agent that protects stomach cells and maintains gastric integrity against various noxious agents<\/span>. It promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, including healing GI ulcers, anastomotic sites, and various GI fistulas, as well as in models of inflammatory bowel disease<\/span>. BPC-157 has demonstrated beneficial effects in models of ulcerative colitis, with no side effects reported in phase II trials<\/span>.<\/span><\/p>\n

Angiogenesis via VEGFR2\u2011Akt\u2011eNOS Signalling<\/span><\/strong><\/p>\n

BPC-157 promotes angiogenesis primarily through the activation of the Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) signalling pathway<\/span>. This activation leads to a downstream cascade involving\u00a0<\/span>Akt<\/span><\/strong>\u00a0and\u00a0<\/span>endothelial nitric oxide synthase (eNOS)<\/span><\/strong>, ultimately promoting endothelial cell proliferation, migration, and survival<\/span>. Increases in VEGF, CD34, and FVIII have been reported in muscle and tendon models, confirming that BPC-157 stimulates angiogenesis<\/span>.<\/span><\/p>\n

Modulation of the NO\u2011System and Free Radical Counteraction<\/span><\/strong><\/p>\n

BPC-157 exerts a distinctive effect on nitric oxide (NO) levels \u2014 capable of both increasing and decreasing NO as needed \u2014 always combined with counteraction of free radical formation<\/span>. This dual ability to modulate NO while preventing oxidative damage is central to its tissue-protective profile. BPC-157 controls angiogenesis and the NO\u2011system’s healing functions while counteracting the pathological presentation of neurodegenerative diseases in animal models<\/span>.<\/span><\/p>\n

Inhibition of Inflammatory Cytokines and Enhancement of Growth Hormone Receptor Expression<\/span><\/strong><\/p>\n

BPC-157 enhances growth hormone receptor expression and reduces inflammatory cytokines<\/span>. In preclinical models, it has demonstrated improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries<\/span>.<\/span><\/p>\n

Organoprotection: Translating Cytoprotection to Other Organs<\/span><\/strong><\/p>\n

The cytoprotective effects observed in the gastrointestinal tract can be translated to other tissues through organoprotection<\/span>. BPC\u2011157 therapy effectively combines various tissue healing and lesions counteraction across multiple organ systems<\/span>.<\/span><\/p>\n

Key Research Applications for BPC-157 (5mg \/ 10mg)<\/span><\/h2>\n

BPC-157 (5mg \/ 10mg) research peptide<\/span><\/strong>\u00a0is a versatile tool with applications spanning several domains of biomedical research.<\/span><\/p>\n

1. Gastrointestinal & Mucosal Research<\/span><\/h3>\n

As a peptide that promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, BPC\u2011157 is a valuable tool for studying GI protection and repair. Research applications include:<\/span><\/p>\n